May 31, 2016 · STOCK Act disclosure
Representative James B. Renacci (Republican-OH) bought Biogen Inc., a stock transaction, valued at $1,000 - $15,000. The trade took place on May 31, 2016 and was disclosed on June 7, 2016 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.